| Ytd | 24.06% | |
| 1y | 26.05% |
| Open | Prev Close | 100.61 | Low | High | Mkt Cap | 2.30B | |||
| Vol | 0.00 | Avg Vol | 305.50K | EPS | 2.58 | P/E | 39.00 | Forward P/E | 33.90 |
| Beta | 0.52 | Short Ratio | 3.86 | Inst. Own | 100.74% | Dividend | 1.00 | Div Yield | 0.98 |
| Ex Div Date | 05-21 | Earning | 05-05 | 50-d Avg | 97.32 | 200-d Avg | 95.08 | 1yr Est | 118.75 |
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outp
Citizens analyst Daniel Stauder maintains LeMaitre Vascular (NASDAQ:LMAT) with a Market Outperfor
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q2 GAAP EPS of $0.79-$0.84 vs $0.75 analyst estimate.
LeMaitre Vascular (NASDAQ:LMAT) raises FY2026 GAAP EPS guidance from $2.81-$3.01 to $2.93-$3.08 vs $
LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.68 per share which beat the analys
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outp
Roth Capital analyst Kyle Bauser reiterates LeMaitre Vascular (NASDAQ:LMAT) with a Buy and raises
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight
Citizens analyst Daniel Stauder maintains LeMaitre Vascular (NASDAQ:LMAT) with a Market Outperfor
LeMaitre Vascular (NASDAQ:LMAT) is looking for FY2026 GAAP EPS of $2.81-$3.01 vs $2.58 analyst estim
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q1 GAAP EPS of $0.64-$0.69 vs $0.61 analyst estimate.
LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.68 per share which beat the analys
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outp
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings
Stocks Which Set New 52-Week Low Yesterday, October 9th
Stocks Which Set New 52-Week Low Friday, October 5th